| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.064 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |